Gillian Watt

Gillian Watt is currently Director of Pharmacology within the Protein Degradation DPU at GlaxoSmithKline. Prior to joining GSK in December 2016, I worked at UCB Pharma for 15 years and before that at James Black Foundation. I have worked across several therapeutic areas and across all stages of the drug discovery. I have a B.Sc.(Hons) in Pharmacology (University of Aberdeen) and a Ph.D. in Analytical Pharmacology (University of London).